Protagenic Therapeutics Faces Delisting Concerns
Ticker: PTIXW · Form: 8-K · Filed: Jul 26, 2024 · CIK: 1022899
| Field | Detail |
|---|---|
| Company | Protagenic Therapeutics, Inc.\New (PTIXW) |
| Form Type | 8-K |
| Filed Date | Jul 26, 2024 |
| Risk Level | high |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-rules, regulatory
Related Tickers: PTIX
TL;DR
PTIX might get delisted, stock could be toast.
AI Summary
Protagenic Therapeutics, Inc. filed an 8-K on July 26, 2024, reporting a notice of delisting or failure to satisfy continued listing rules as of July 24, 2024. The company, previously known as Atrinsic, Inc., is incorporated in Delaware and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates potential issues with Protagenic Therapeutics' ability to remain listed on its exchange, which could significantly impact its stock liquidity and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to trade on a major exchange, posing a significant risk to its operations and shareholder value.
Key Players & Entities
- Protagenic Therapeutics, Inc. (company) — Reporting company
- July 24, 2024 (date) — Date of earliest event reported
- July 26, 2024 (date) — Filing date
- Atrinsic, Inc. (company) — Former company name
FAQ
What specific listing rule or standard has Protagenic Therapeutics failed to satisfy?
The filing does not specify the exact listing rule or standard that Protagenic Therapeutics has failed to satisfy, only that a notice has been issued.
What is the exact date of the delisting notice?
The earliest event reported, which includes the notice of delisting or failure to satisfy a continued listing rule, is dated July 24, 2024.
What was Protagenic Therapeutics previously named?
Protagenic Therapeutics, Inc. was formerly known as Atrinsic, Inc.
In which state is Protagenic Therapeutics incorporated?
Protagenic Therapeutics, Inc. is incorporated in Delaware.
What is the primary business of Protagenic Therapeutics?
Protagenic Therapeutics, Inc. operates in the Pharmaceutical Preparations industry, SIC code 2834.
Filing Stats: 685 words · 3 min read · ~2 pages · Grade level 13 · Accepted 2024-07-26 17:30:13
Key Financial Figures
- $1.00 — ties to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810
Filing Documents
- form8-k.htm (8-K) — 40KB
- 0001493152-24-029295.txt ( ) — 251KB
- ptix-20240724.xsd (EX-101.SCH) — 4KB
- ptix-20240724_def.xml (EX-101.DEF) — 26KB
- ptix-20240724_lab.xml (EX-101.LAB) — 36KB
- ptix-20240724_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PROTAGENIC THERAPEUTICS, INC. Date: July 26, 2024 By: /s/ Alexander K. Arrow Name: Alexander K. Arrow Title: Chief Financial Officer 3